Monthly Archives: November 2009

FormCap Corp. (FRMC.PK) is “One to Watch”

November 30, 2009

FormCap Corp. is an emerging oil & gas exploration and development company. With a primary focus on the discovery and development of oil in the Continental United States, the company has assembled 4,800 acres of oil and gas mineral leases, together called the Weber City Prospect, located in Curry County, New Mexico.

The Weber City Prospect has been defined by detailed geological information including well log data, seismic, Landsat and independent third party geological interpretation. After thorough review of the collected data, FormCap believes there is potential to drill up to 100 wells that could produce over 300 million barrels of oil.

The initial well will be drilled to a total depth of 6,500′ to test four potential productive hydrocarbon zones; the San Andres, Clearfork, Wolfcamp and, the primary objective, the Cisco Formation. The company has also outlined multiple secondary objectives in the primary producing zones of the Permain Basin of New Mexico and Texas.

The Permian Basin is very prolific and well known for its oil production. Owning their leases 100%, FormCap is fully in charge of its exploration and drill plan. The four well established formations should provide FormCap with a relatively low risk opportunity as the company’s experienced management team dedicates all efforts towards profitability.

Let us hear your thoughts: FormCap Corp. Message Board

China Gengsheng Minerals, Inc. (CHGS.OB) Renews Full Service Contract with Two Companies

Today, high tech industrial materials products company, China Gengsheng Minerals, Inc. announced that it has renewed a full-service refractory contract and regenerative bricks contract with Shandong Iron and Steel Group, Rizhao Subsidiary. The full-service contract will begin on December 1st, 2009 and last to November 10th, 2010; the regenerative bricks contract lasts for 18 months. The combined value of the two contracts is estimated at approximately $9.0 million. Payments will be made on a monthly basis in accordance with the production schedules.

Gengsheng, with products capable of withstanding high temperatures, saving energy and boosting productivity in steel and oil industries, provides “full services” to China’s steel mills in the form of refractory product installation, testing, maintenance, repair and replacement. The company recently renewed three other full-service, refractory contracts for another year. The combined total value of the three renewal contracts is estimated to be approximately $7.3 million.

Mr. Shunging Zhang, Chairman and CEO of Gengsheng, commented, “I am encouraged by the two contracts with Shandong Iron and Steel Group, Rizhao Subsidiary. As our biggest customer and strategic partner, Shandong Iron and Steel Group, Rizhao Subsidiary has generated solid revenue growth and stable revenue streams for us. Meanwhile, the high value-added products such as the full- service programs and regenerative bricks typically enjoy higher gross margins.”

Let us hear your thoughts below:

November 30th CEOcast Weekly Newsletter

Companies featured in this edition of the newsletter: ACTC, ENZ, NWCI, OMCM, ONBI, PHC, XSNX

Markets continued to display strength early on during this holiday shortened week, only to be led lower on Friday by concerns stemming from the announcement that the UAE was attempting to restructure debt with potentially adverse effects on lenders, chiefly, European banks. All told, the Dow finished marginally in negative territory, losing 0.1% on the week, surrendering 8 points to close at 10309, up 17.5% on the year. The Nasdaq performed slightly worse, losing 0.4% to close at 2138, while the S&P 500 finished the week flat and the Russell 2000 lost 1.3% to put their yearly gains at 20.8% and 15.6% respectively.

Stronger than expected Existing Home Sales reported on Monday helped indices climb to their highest levels of the week, as sales in October rose 10.1% to 6.1 million homes, handily beating forecasts for 5.7 million, on the strength of incentives created by the first-time buyers tax credit. Markets held Monday’s gains in two quiet sessions leading up to the Thanksgiving break, but as investors returned to action on Friday, they were greeted by news that European and Asian markets had reacted badly to the announcement of debt restructuring plans by the UAE, which ultimately led markets into negative territory on the week.

With US markets closed on Thursday, their Asian and European counterparts plunged on concerns about the potential effects of restructuring up to $20 billion in UAE debt coming due in the next 18 months. As many European banks are among those with the most exposure to the loans, markets reacted badly, with the FTSE declining over 3% on Thursday despite rebounding on Friday.

What should investors look for this week? Earnings reports will be light, but expect results from retailer Aeropostale (NYSE: ARO) on Wednesday after the close, followed on Thursday pre-market by home builder Toll Brothers (NYSE: TOL), with software developer Novell (NASDAQ: NOVL) reporting after the close that same day.

Economic releases for the week begin on Monday with the Chicago PMI due out at 9:45am. On Tuesday morning, look for Construction Spending and Pending Home Sales for October along with the ISM Index for November at 10:00am, followed by Truck and Auto Sales for November at 2:00pm. Challenger Job Cuts for November will be released on Wednesday morning at 7:30am, followed by ADP Employment for November at 8:15am, weekly crude inventories at 10:30am, and the Fed Beige Book for November at 2:00pm. On Thursday, weekly initial jobless claims and continuing claims will be released at 8:30am along with Revised Q3 Productivity and Q3 Employment Cost Index, followed at 10:30am by ISM Services for November. The week wraps up with Nonfarm Payrolls, the Unemployment Rate, Average Workweek and Hourly Earnings, all for November, due out at 8:30am, followed at 10:00am by Factory Orders for October.

Conference schedules pick up following the holiday; Piper Jaffray hosts their two-day Healthcare Conference in New York beginning on Tuesday along with the Citigroup Global Markets Basic Materials Conference. On Wednesday, the Jeffries Energy Summit begins in New York along with the Morgan Stanley Transportation Corporate Access Day, JP Morgan SMid Cap Conference, and two-day Bank of America and Merrill Lynch Credit Conference. Advanced Cell Technology (OTCBB: ACTC), ImmunoCellular Therapeutics (OTCBB: IMUC) and NewCardio (OTCBB: NWCI) present Thursday at the LD Micro Conference in Los Angeles, which brings together 75 presenting companies with over 100 institutions focused on investing in small and micro cap companies across a breadth of industries. Credit Suisse Group hosts its Technology Conference in Phoenix on Thursday.

Pioneer Behavioral Health (AMEX: PHC), a provider of inpatient and outpatient behavioral health services, announced last week that it has been awarded a contract renewal from the Detroit-Wayne County Community Mental Health Agency representing total commitments in excess of $10 million if all option years are exercised. PHC was the incumbent bidder for the contract, having serviced the residents of Wayne County for over five years prior to being awarded the new multi-year contract, which began on May 1, 2009. Under the terms of the contract, PHC will provide Access and Eligibility Services, Crisis Intervention, and Information and Referral, including an array of services delivered via Call Center operations and electronic review of records, change of level of services, credentialing and related behavioral services designed to help residents of Wayne County make informed behavioral health choices. Shares lost sixteen cents on the week to close at $1.00.

OmniComm Systems, Inc. (OTCBB: OMCM), a leader in integrated electronic data capture solutions for clinical trials, announced last week that its TrialMaster EDC solution has been chosen by Beardsworth, a full service contract research organization, to assist in a Phase II vaccine study that will enroll approximately 340 patients at ten sites over the course of three years. OmniComm and Beardsworth plan electronic imports of data to TrialMaster utilizing OmniComm’s native template matching subsystem. Electronic exports from TrialMaster EDC to Beardsworth’s BNet portal will be achieved utilizing OmniComm’s new RESTful Web Services, Application Programming Interface (API). This API technology, developed using a RESTful Web Services architecture, leverages CDISC standards and allows for easy integration with external data sources like BNet. The agreement adds Beardsworth to the list of clients participating in OMCM’s already successful CRO preferred program. Shares remained unchanged at $0.20 on the week

One Bio (OTCBB: ONBI), a company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural and health supplements and organic products, announced last week that its subsidiary, Green Planet Bioengineering, has entered into a distribution agreement with The Chinese Society of Traditional Chinese Medicine, under which, the Society has agreed to include ONBI’s recently launched over-the-counter natural and health supplements and beauty products to its network, distributing traditional and herbal medicine products throughout China, the US and European markets. Management expects to see improved sales of over-the-counter natural and health supplements as a result of the Society’s 30,000 points of sale in China and 3,000 in the United States; the agreement marks a key step in the company’s aggressive distribution strategy. Shares lost 40 cents on the week to close at $6.10.

XsunX (OTCBB: XSNX), a developer of advanced, thin-film photovoltaic (TFPV) solar cell technologies and manufacturing processes, announced last week that its Chief Technology Officer, Robert Wendt, has been invited to address over 300 senior thin-film experts at the second annual Thin-film Solar Summit in San Francisco, CA on December 1. Mr. Wendt will be part of a panel discussion on thin-film breakthrough technology along with several industry leading scientists, and will discuss the latest in cell and module innovation from a technical perspective, specifically advancements in high-rate single cell deposition of CIGS layers. The Thin-film Solar Summit U.S. attracts highly respected solar industry professionals including manufacturers, investors, engineers, scientists, project developers, researchers and key service providers looking to push the thin-film industry forward. Shares gained just over a penny on the week to close at $0.175.

On the Wires: Vertically integrated biotechnology company Enzo Biochem (NYSE: ENZ), announced last week that its Board of Directors has approved the termination of Shahram K. Rabbani’s as the company’s Secretary and Treasurer; Mr. Rabbani will continue to serve as a Director of the company. The board has appointed Dr. Elazar Rabbani to serve as Secretary and Barry W. Weiner to serve as Treasurer, effective immediately. Dr. Rabbani currently serves as the company’s Chairman of the Board and Chief Executive Officer and Mr. Weiner currently serves as the President, Chief Financial Officer, Principal Accounting Officer and as a member of the Board of Directors.


NewCardio, Inc. (OTCBB: NWCI) $0.70

With all the attention surrounding health care reform and generally improved medical practices of late, companies with products that can facilitate more efficient patient care have been receiving increased attention from investors. NewCardio is a company seeking to incorporate novel, state-of-the-art technology to improve the diagnostic accuracy and precision of the analysis of signals from electrocardiograms (ECGs) in order to better diagnose heart conditions. The company’s focus on improving one of the most commonly employed medical diagnostic tests in use today presents investors with an opportunity to consider a company engaged in serving an extremely robust market at a time when improving efficiencies within the health care space is at the forefront of public policy initiatives.

What makes NewCardio’s technology unique is that it takes the standard 12 lead ECG input performed over 250 million times annually in the developed world, and displays the signals in a three dimensional output, providing significantly increased sensitivity, accuracy and precision to the potentially lifesaving diagnostic tool. In addition to providing for a more thorough, accurate diagnosis of potential heart conditions, it allows for the capability to automate what has historically been a more costly and labor intensive process. In order to more fully capitalize on the multibillion dollar a year potential market, the company is currently developing three unique solutions addressing distinct and rapidly growing segments of the industry, which it expects will greatly enhance its ability to diversify its revenue stream.

Initially, NewCardio has implemented its technology in cardiac toxicity testing done in conjunction with FDA mandated clinical trials for new drug development. Utilizing the 3D technology, the company expects that it will significantly reduce the costs associated with cardiac safety trials and will accelerate the drug development process, as clinical trial service providers, such as Contract Research Organizations (CROs) and drug companies will be able to automate the traditionally time consuming and costly manual or semi-automated processes typically done in conjunction with these trials; estimates put the potential market on cardiac toxicity testing near $$750 million annually for early and late-state drug testing. The company’s product offering targeted at facilitating clinical ECG activities, called QTinno, has already been licensed by several top tier CROs to deliver fully automated safety analysis of cardiac safety in drug development just months after its launch in August, with agreements expected to follow from additional leading CROs, ECG core labs, Phase I units and pharmaceutical companies.

Along with clinical applications, the company expects that use of its improved diagnostic tool VisualDX will have similarly positive effects on hospital operations, as the ability to more accurately and expeditiously diagnose heart conditions in Emergency Departments has the potential to save thousands of lives annually, in addition to significantly reducing costs associated with unnecessary hospital admissions resulting from inaccurate ECG readings. With 70 million ECGs performed in ERs in the US alone each year, the potential market for hospital applications has been estimated to be in excess of $2 billion annually. In addition to clinical and hospital applications, the company also plans to employ the technology in home monitoring of chronic heart conditions, which could potentially revolutionize the way patients monitor their disease outside of a healthcare facility. A unique, wireless hand held device (CardioBip) that could transmit heart information remotely to doctors is currently in development which would enable complete cardiac assessment outside of the immediate care of a physician, allowing for round the clock observation without the high costs associated with hospital stays.

To complement its innovative technology platform, the company also has a strong management team with backgrounds across a breadth of industries that serve to guide both product development and corporate operations. Spearheaded by Chairman Mark Kroll, the most prolific inventor of electrical medical devices in the world with over 280 patents to his credit, management includes veterans from the medical device, technology, CRO, biotechnology and finance industries, including high ranking executives from organizations such as Intel and St. Jude Medical with extensive experience in designing and marketing cutting edge medical devices. Along with leading technological development and attracting early adoption agreements for QTinno with several major CROs, management and Board have recently demonstrated their commitment to both the technological concept and the company itself, by buying up more than half of a recent $2.9 million private placement offering that, when coupled with a $3 million dollar line of credit, is expected to sufficiently fund operations into the second half of 2010, by which time management expects considerable strength in the sales of QTinno.

According to a regulatory filing, the company has begun to explore strategic relationships with one or more partners, to provide capital and to enhance the development and marketing of its products, with a primary focus on its 3-D Technology platform, specifically Visual3Dx for the urgent care market and CardioBip for cardiac monitoring applications. By the second half of next year, the company expects activity in clinical trials to drive acceptance of its automated cardiac safety tool.

With strong technological improvements made to an already well established medical test enabling reduced costs and improved diagnostic capabilities for one of the leading causes of death worldwide, NewCardio appears to be well positioned to capitalize on the growing trend towards providing better care while improving efficiencies within the healthcare system. The ability of their platform to provide more accurate readings in a less time consuming and less labor intensive manner has the potential to allow for better care and reduced cost across a wide breadth of applications, making it an extremely intriguing and timely prospective investment as the focus on more efficient healthcare continues to attract significant national attention.

Clarient, Inc. (CLRT) Announces Exclusive License from Minerva Biotech for New Cancer Biomarker

Clarient, Inc. disclosed today details of an exclusive license for bringing to market a test developed by privately-held Minerva Biotechnologies. CLRT, as a leading provider of cancer diagnostic testing solutions, is an ideal choice for the development and commercialization of this test. The test identifies a specific biomarker, the MUC1* protein, which is associated with multiple cancers, including breast cancer.

Ron Andrews, CEO of CLRT, noted the “potential impact on cancer diagnostics” offered by this testing methodology for MUC1*, pointing out that while still “early in the evaluation process” this test offers advantages for diagnosing, selecting and monitoring the efficacy of therapy for solid tumors.

Andrews elaborated on the synergy between Minerva, its biomarker technology and CLRT’s business model, by saying, “Our growth model includes collaborating with academia and innovative companies, wherein the value of new biomarkers are defined.” Andrews went on to say that, once the test is validated, CLRT would use its “robust national pathology distribution network” to move forward with commercialization.

Founder and CEO of Minerva, Dr. Cynthia Bamdad, cited the “great deal of attention” surrounding Minerva’s discovery of the altered MUC1* on embryonic stem and cancer cells as evidence to be excited about the licensing agreement with CLRT.

“This is the first direct evidence that cancer cells grow by hijacking a normal stem cell mechanism that usually exists in a dormant state on healthy adult cells.” explained Bamdad.

Dr. Bamdad indicated that Minerva “has compelling evidence” showing cancer cells’ resistance to anti-cancer drugs is linked to the production of MUC1*. Bamdad pointed out that a recent Minerva article on blocking MUC1*, as a means of reversing “acquired resistance to cancer drugs”, appeared in this month’s journal Breast Cancer Research and Treatment.

CLRT estimates the development window for a test, of the predictive value of measuring MUC1* in patient samples, at about one year. As of yet, no MUC1*-targeting drug exists. However, this most recent test would identify patients for whom a MUC1*-disabling drug would be effective, thus there exists the potential to realize both types of product. CLRT and Minerva are intent on a collaborative effort in evaluating the clinical utility of the biomarker, and will validate the methodology via presentations and supporting papers to be presented at major cancer research and treatment symposia.

Andrews commented on the progress made in biomarkers for identifying cancers, saying “we need to be proactive in evaluating new markers, such as those implicating MUC1*.” Andrews further pointed out the five years CLRT has spent building a “commercial channel that could deliver complex cancer testing information into every community in the US, and building out a base menu of services to support the community pathologists.”

A final comment by Andrews hinted at the massive potential value of MUC1*, “especially for women who have developed a resistance to certain targeted therapies”, which could become a significant product in CLRT’s arsenal, promising steady returns for his Company’s investors.

Let us hear your thoughts below:

Newport Digital Technologies, Inc. (NPDT.OB) to Attend Southern California Investment Association Conference

Newport Digital Technologies Inc. will attend the Southern California Investment Association Conference in Irvine, California on Saturday, December 5th. The conference will highlight about 12 to 15 emerging growth companies that are considered to be small-cap or mid-cap according to their market capitalizations.

These often overlooked companies will make presentations to guests at the conference. These guests will include hundreds of influential firms plus associates including broker/dealers, investment and merchant bankers, investment advisors, analysts, financial service and fund managers, capital formation service providers, institutions, media and accredited investors.

The presenting companies are promoted widely to the attendees and in press releases before and after the conference. It is hoped that this conference will build exposure and support for the presenting firms, such as Newport Digital Technologies.

Newport Digital brings world-class technological expertise and creativity – through their unique relationship with some of Taiwan’s leading technology centers – to the design and implementation of innovative made-to-order solutions for their clients so that they may take full advantage of the possibilities for the increasingly sophisticated and intelligent applications enabled by the new generation of wireless broadband networks.

Let us hear your thoughts: Newport Digital Technologies, Inc. Message Board

Follow QualityStocks on Twitter!

The equity markets are constantly moving and it is imperative that an active trader can find out what is happening in real-time. Even if you aren’t trading all day long – it is important to stay on top of the latest-breaking news. That is why we created our Twitter account just for you.

By following us at Twitter, you will be right on top of the action in the micro-cap and small-cap markets. You will receive short alerts regarding stock movements, news releases, and our new “Ones to Watch.” Every day we send dozens of tweets to bring our followers the hottest stocks and headlines.

The news about the quality of our Twitter service is spreading rapidly. In the very short time since the service was launched, we already have over 1,800 followers.

If you like to start following us, please visit our page at:

Seahawk Drilling, Inc. (HAWK) is “One to Watch”

Seahawk Drilling, Inc. is focused on providing contract drilling services to the oil and natural gas exploration and production industry in the Gulf of Mexico. Operating the second largest fleet of jackups in the Gulf of Mexico, the company’s customers include independent oil and natural gas producers, drilling service providers and Petróleos Mexicanos (PEMEX), the state-owned petroleum company of Mexico. Competition ranges from large, international drilling companies to smaller companies who focus solely on the Gulf of Mexico shelf.

Seahawk’s strategy as an independent company is to improve the profitability, efficiency and reputation of its core business: providing jackup drilling services to the exploration and production industry in the Gulf of Mexico. Leveraging its strengths, which includes the large jackup fleet, existing relationships with customers and its experienced management team, the company strives to more effectively focus on operations and potential for growth; delivering greater value for stockholders.

Although earnings have been affected by the current economy and lower commodity prices, the company remains steadfast and is optimistic for the future. Randall D. Stilley, President and CEO of Seahawk, commented, “With natural gas prices at record lows, the Company faces a challenging market in the near term. However, in the midst of hurricane season and weak natural gas prices, we have seen a modest improvement in inquiries and bidding in the U.S. recently, as some of our customers are taking advantage of lower well costs, and the general sentiment towards future gas prices has improved.”

Currently, 29.72% of the shares outstanding are held by insiders and 4.60% are held by institutions. Two analysts believe the company is a “Hold”, while one believes it’s a “Strong Buy”. As of last report, Seahawk had $18.1 million in cash and cash equivalents with $94.3 million in current liabilities. Generating $409.4 Million in annual sales, the company trades at a market cap of $314.4 million.

Let us hear your thoughts below:

Nicholas Financial, Inc. (NICK) is “One to Watch”

Nicholas Financial, Inc. provides direct consumer loans and purchases installment sales contracts from automobile dealers for used cars and light trucks. Nicholas Financial operates a network of forty-nine branch offices in Florida, Georgia, Indiana, Ohio, Kentucky, North Carolina, South Carolina, Michigan, Maryland, Virginia, Alabama and Tennessee. Its software subsidiary, Nicholas Data Services, Inc., designs, develops, supports and sells accounting software to small businesses throughout North America and is the computer automation provider for Nicholas Financial.

Nicholas Financial enables individuals with blemished credit to purchase a vehicle. Vehicles have long held a special place in the hearts of Americans. An American’s car is a symbol of freedom and hope for a future. From the time a teenager receives his learners permit, vehicle ownership gives the freedom to go just about anywhere. A vast majority of Americans will sacrifice a great deal to keep this freedom at all costs. It is this attachment that causes the company to believe that both the subprime borrower and secondary automobile markets will continue to expand.

Over the past year, Nicholas Financial has worked to modernize and strengthen its corporate infrastructure. Their IT staff has upgraded and expanded the company’s computing facilities, which should provide ample processing and data storage capacities for future growth. Going forward, the company will continue to implement efficiencies that will help lower costs and amplify earnings growth once an economic rebound occurs. In addition, Nicholas Financial intends to increase its revenues by adding new branches in the years to come.

As of last report, the company had $204 million in total assets and $116 million in total liabilities. During the second quarter, revenues increased from $13.1 million to $13.7 million year-over-year, while net income increased from $1.6 million to $2.3 million. Trading at a P/E ratio of 13 and Price/Book Value of 0.81, the company is undervalued compared to industry averages.

Let us hear your thoughts below:

Li3 Energy, Inc. (LIEG.OB) to Acquire Puna Lithium Corporation of Chile

Li3 Energy Inc. is pursuing a business strategy to acquire a portfolio of lithium brine deposits in the Americas for the purpose of development and production of lithium. Lithium is used extensively in many clean and green energy applications such as batteries.

The company announced today that it has signed a letter of intent to acquire Puna Lithium Corporation. Puna has an option to acquire up to 85% of 90,000 acres of salar property in Argentina. More importantly, Puna has an option to acquire up to an aggregate 80% interest in 123,000 acres of prime Chilean salar ground located across nine Chilean salars, including Salar de Atacama where Sociedad de Chile (NYSE: SQM) has production facilities.

The Salar de Atacama currently contains the highest economic lithium concentrations in the world as well as some of the lowest processing costs due to its low magnesium content, high evaporation rates and ability to operate year-round. The entire Puna plateau is host to over 70% of the world’s lithium reserves and production.

Li3 Energy also recently announced an acquisition of a lithium brine property in Big Smoky Valley, Nevada. With the recent acquisitions, Li3 Energy has secured approximately 300,000 acres of prime lithium brine properties in the three major politically stable brine production areas in the world. Luis Seinz, CEO of Li3 Energy, said, “These properties will provide the platform for Li3 on the primary production side to execute on its business plan of rapidly developing a vertically integrated lithium production, manufacturing and sales company.”

Let us hear your thoughts below:

Trans-Orient Petroleum Ltd. (TOPLF.OB) Posts FY09 Highlights and Future Projections

Trans-Orient Petroleum Ltd. today announced it has filed its fiscal-year financial results for the year ended July 31, 2009, and notes significant highlights for the year, including preparations for its initial drilling campaign, progress of its business partnership in the works, and independent reserves reports.

“It was a busy year for Trans-Orient in New Zealand, preparing for our initial drilling campaign targeting both conventional and unconventional shale prospects. We are also very excited as we move closer to completion of our strategic business combination with TAG Oil Ltd. (TSX-V: TAO), anticipated to close in mid-December 2009,” Trans-Orient CEO Garth Johnson stated in the press release. “Independent reports by qualified reserves evaluators dated September 2007 and September 2008 have estimated Trans-Orient’s prospective resources at over 14 billion barrels of original oil in place, adding immense upside to TAG’s already proven producing reserve base in the Taranaki Basin.”

The estimates completed by qualified reserves evaluators Sproule International Ltd. and by AJM Petroleum Consultants are available on Trans-Orient’s Website

The company posted a net loss of $4.7 million for the fiscal year 2009, reflecting a $3.5 million loss on investment. At July 31, 2009, the company had cash and cash equivalents of $4.89 million, $4.93 million in working capital, and no debt.

Johnson said that upcoming developments are expected to generate significant revenue and will leverage the company’s growth.

“In addition to TAG’s proved producing assets, significant near-term production growth exists through further development drilling at Cheal, as well as follow-up high-impact, lower-risk exploration drilling within a proven commercial discovery fairway,” Johnson stated. “The combined companies will have more than $11 million in working capital, no debt, solid monthly production revenue and 100% control of all assets, creating a dynamic, high-growth international oil company.”

Let us hear your thoughts below:

Cannabis Science, Inc. (CBIS.OB) Gets New Advisory Board Members

Cannabis Science Inc., best known for its research and development in the medical uses of marijuana, has announced that Dr. Ben Johnson, Dr. Allan Shackleford, and Dr. William Courtney, have all accepted membership on the company’s recently formed Scientific Advisory Board. Already serving on the board are Dr. Mitch Earlywine, Ph.D. and Dr. Ritchard Fishman, M.D. The addition of several prominent scientists and physicians is expected to help hasten the company’s FDA submissions.

Dr. Ben Johnson is a complementary and alternative medicine physician, with a degree in Osteopathy in addition to M.D. and N.M.D. degrees. He is the founder and previous director of the Immune Recovery Clinic in Atlanta, Georgia. He served in Vietnam, and was a flight surgeon in the Army Reserve for many years. He was also a Senior Aviation Medical Examiner for the FAA for 12 years. Dr. Johnson is currently the owner of Dr. Ben Johnson Services, LLC, where he consults with patients and health care professionals across the world, emphasizing complementary oncology and natural health care.

Dr. Alan Shackleford, a Denver physician, is a graduate of the University of Heidelburg School of Medicine, with an extensive background in clinical medicine, nutrition support, metabolism analysis, micro-vascular surgical techniques, and stress management techniques in the treatment of obesity and performance anxiety. Dr. Shackleford is also an instructor in genetics at the University of Maryland, and has lectured at Harvard Medical School in clinical training for behavioral medicine.

Dr. William Courtney, in addition to holding a B.S. in Microbiology and M.D. degree, has a Post Doctorate in Forensic Examination and Forensic Medicine. He is a member of the International Cannabinoid Research Society, the International Association of Cannabis as Medicine, and the Society of Clinical Cannabis. Dr. Courtney teaches Continuing Medical Education (CME) courses in clinical cannabis, and a Survey Course on Endogenous Cannabinoid System, and hosted the Second International CB2 Conference in California.

Cannabis Science president and CEO, Dr. Robert Melamede, Ph. D., commented on the new board members. “We have been enormously gratified by the very positive reaction to the company’s plans by those who are most familiar with the need for medical cannabis products. The fact that so many prominent experts understand the importance of what we are doing and support our efforts shows that we are on the right path. We are putting together a very powerful team and with their help we will successfully blend the revolutionary power of capitalism with activism moving the company forward.”

Let us hear your thoughts below:

Gabelli Equity Trust (GAB) Continues its Solid and Stable Run in the Income Sector

Following the in-flows and out-flows of the mutual fund industry offers insight as to what the general investor is up-to. As might be expected, in a poor economy, investment monies tend to flow out of mutual funds. This reality is the current trend with investment capital leaving funds. The astute investor, however, may see this as an opportunity. Not following the “herd” is how profit is made.

The opportunities are apparent and transparent, which is the advantage of mutual funds. An investor can easily see where and what is being invested in. Commodities, “blue-chips” or a blend is the choice. What is being invested in by the professionals is available for inspection. Some, however, are just more consistent than others. One needs to pick just as carefully as if stocks were to be picked. This is simply because the investor is picking a group of stocks that happens to be called a mutual fund. In either case, stock or fund, due diligence needs to be undertaken.

Gabelli Equity Trust, a diversified mutual fund, works to invest in a variety of sectors but tends to focus on energy and utilities. Other sectors of investment that the company invests in include telecommunications, cable, satellite and an array of diversified industrial companies.

In a general sense, one might refer to the company as directing its focus toward solid growth stocks. There is some, but very little, tendency toward risk in the stocks that the company invests in. Although there is a diversification of sectors and stocks, there is focus and direction in how the company has oriented its portfolio. Overall, the mix of assets invested in by the company has been consistently stable through recent times and continues to produce reliable returns. Fees have been slightly less in recent months but this is consistent with an overall trend in the mutual fund market.

For the most part, what needs to be paid attention to when it comes to Gabelli & Company Inc. is that it has come through a difficult economic time with little damage to profit. The company’s reporting seems to show that it has had little reduction in overall profit. This is not to suggest that there was not a small reduction but rather that the company has been following a pattern of investment that is stable and fairly resilient. One must understand that past results are not an indication of future returns but that Gabelli Equity Trust has been investing profitably in a difficult economic environment and paying a nice little bit of income on a reliable basis.

Let us hear your thoughts below:

Muscle Flex Inc. (MFLI.PK) Announces Acquisition of Web Domain and Launches an Updated Web Site

Muscle Flex Inc. announced this morning that it has acquired the web domain and has launches a new updated site ahead of the national release of the Beagle StepFit commercial. To visit the new site, click on the following link:

“Acquiring the web domain was an important step in ensuring that all web traffic generated from our advertising is captured with as little bleeding as possible,” commented Danny Alex, CEO of Muscle Flex Inc. “I regard our web traffic to be one of our most valuable assets and now with the acquisition of, Muscle Flex Inc. owns the important web properties for capturing customers as well as maximizing search results and web optimization.”

The partnership of Muscle Flex television media and its online properties is one that promotes leading edge data capture, efficiency and entertainment value for the customer. Cross pollinating the Muscle Flex customer database and communicating with them effectively, without intrusion, is an important strategy in developing ongoing sales and maintaining a close relationship with the customer.

Let us hear your thoughts: Muscle Flex Inc. Message Board

VIASPACE, Inc. (VSPC.OB) Announces Filing of Amended Form S-1

VIASPACE Inc., a clean energy company growing Giant King(TM) Grass as a low-carbon, renewable energy crop, announced that on November 25, 2009, it filed an amended Form S-1 with the Securities and Exchange Commission to list its majority-owned subsidiary, VIASPACE Green Energy Inc. (VGE), as a separately reporting public company.

VGE’s shares are expected to be traded on the OTC Bulletin Board. VIASPACE Inc. anticipates that its majority ownership in VIASPACE Green Energy, current management and operations of VGE, and VGE’s focus on renewable energy will remain unchanged.

VIASPACE Chief Executive Carl Kukkonen reiterated that with separate reporting, VGE’s business, growth potential and financial progress will be more visible and offer investors a clearer view of VGE as an investment opportunity in renewable energy. Because VIASPACE Inc. expects to maintain its majority ownership of VGE, VIASPACE Inc. shareholders will benefit from VGE’s expected business growth and appreciation in value.

The S-1 filing, effective registration by the SEC and exchange-listing of the common shares of VGE also meet a condition for the second closing of the October 21, 2008, acquisition of Inter-Pacific Arts (IPA). VIASPACE Inc. is in negotiations with the seller of IPA to effect the second closing, and the deadline for the second closing has been extended from November 26, 2009, to December 15, 2009.

Let us hear your thoughts: VIASPACE, Inc. Message Board

TapImmune, Inc. (TPIV.OB) Secures Additional Funding

TapImmune Inc., a biotechnology company specializing in the development of immunotherapeutic vaccines for cancer and infectious diseases, announced last week that within the last 60 days the company secured an additional $600,000 in equity funding, bringing the total for the last six months of 2009 to over $1,000,000. The recent investors acquired $.80 units with each unit comprised of one share and one warrant exercisable at $1.20 for a period of 5 years.

The recent restructuring taken place at TapImmune has provided a more secure framework from which to pursue investment and industry partnerships. The company is dedicated to working diligently to secure additional funding and to move its product development and business forward.

Let us hear your thoughts: TapImmune, Inc. Message Board

Ironwood Gold Corp. (IROG.OB) Makes National News with the Acquisition of Additional Mineral Rights at Cobalt Canyon Gold Project

One company that has been stirring up a storm in the desert is the Arizona based Ironwood Gold Corporation. A noted mineral exploration and development company, Ironwood Gold is building a unique portfolio of prospective properties containing known deposits of strategic precious metals in mine-friendly North America.

Today, Ironwood Gold took a major step towards enhancing their future with the acquisition of mineral rights at Cobalt Canyon Gold Project in Nevada which contain 32 additional Federal Iode mining claims. With the additional 32 claims covering 274 acres, the project, which was originally believed to cover a total of 422 acres, now encompasses an incredible grand total of 696 acres in the Chief or Caliente mining district of southeastern Nevada, about 115 miles northeast of Las Vegas and 5 miles north of the town of Caliente.

Project data on the Cobalt Canyon Gold Project has indicated there is the potential for 1.5 million ounces of gold with possibly a higher number which may be obtainable. An authored N.I. 43-101 compliant report strongly recommends plans which could lead to the development of a viable underground mine and the possibility that this property may also hold tonnages and grades that could support an open-pit mine. If these projections come to fruition, the project could help Ironwood Gold become a leader in their industry.

One of the leaders at Ironwood Gold is their President Robert Reukl. Reukl has been employed as a geologist in the mineral exploration and mining business for over 25 years and had a very successful career and became a noted leader in his industry prior to coming to Ironwood. When asked about the potential of the Cobalt Canyon Gold Project, Reukl was quoted as saying, “These additional claims cover the ground from which surface rock samples indicate a high probability of mineralization at depth. If the mineralization is present, this larger claim block increases the possibility of open pit mining in addition to underground ore extraction, and provides room for recovery facilities and waste disposal management.”

Currently, Ironwood Gold is trading in the $0.81 range and may grow into the over-the-counter gem that every investor dreams of capturing before the institutional members on Wall Street take hold.

Let us hear your thoughts below:

Incyte Corp. (INCY) Inks License Agreement with Novartis for Oncology Treatment

Incyte Corp. is a development company focused on oncology, inflammation and diabetes treatments. The company recently announced an agreement with Novartis regarding two of its investigational hemotology-oncology therapies.

INCB18424 is an oral inhibitor in phase III development for myelofibrosis, a potentially fatal condition that includes bone marrow failure, splenic enlargement and debilitating constitutional symptoms. INCB28060 is an oral inhibitor that will soon be in phase I development as treatment for multiple cancers.

The license and collaboration agreement calls for Incyte to keep the exclusive rights for the development and commercialization of INCB18424 in the United States. Novartis will be responsible for future development and commercialization of INCB18424 outside of the United States, as well as future worldwide development of INCB28060.

“This agreement reflects our objective to retain U.S. rights to INCB18424 and puts us in a strong position to transition Incyte into a successful commercial company with sufficient resources to continue to advance other promising compounds in our pipeline. Additionally, the appreciation from Novartis for INCB18424’s potential to treat the unmet patient need in myelofibrosis and other cancers, and their proven success in rapidly commercializing new targeted oncology treatments, were determining factors in our decision to choose Novartis as our collaborative partner,” Paul A. Friedman, Incyte’s president and CEO stated in the press release.

Per the agreement, Novartis will make an initial payment of $150 million to Incyte, as well as an immediate $60 million milestone payment for the launch of the European phase III trial of INCB18424, COMFORT-II, that began in July of this year.

Let us hear your thoughts below:

Derma Sciences, Inc. (DSCI.OB) Plans Reverse Stock Split

Last week, specialty medical device and pharmaceutical company Derma Sciences, Inc. announced that its shareholders granted Derma Sciences’ Board of Directors the authority to implement a reverse stock split in the range of 1-to-5 and 1-to-10.

Derma Sciences’ Board of Directors anticipates the reverse split to occur in the near future. The precise reverse split ratio will be determined in accordance with the then prevailing market conditions.

For the 20-day period following implementation of the reverse split, Derma Sciences’ ticker symbol will be “DSCID” to reflect the post-split price. Following that period, the ticker symbol will revert to “DSCI.”

Ed Quilty, Chairman and CEO of Derma Sciences, commented, “We have filed an application to list our stock on the NASDAQ Global Market or NASDAQ Capital Market. The reverse stock split our stockholders approved at today’s special meeting will enable Derma Sciences to meet the minimum share-price requirements of the NASDAQ listing.”

Let us hear your thoughts below:

GWS Technologies, Inc. (GWSC.OB) Slated to Begin Distribution of Solaranda™ Technology

Alternative energy company GWS Technologies, Inc. recently announced that it is anticipated to begin distribution of the Solaranda™ Solar Shade Structure, a project that contributes to their ongoing development of solar and wind-powered renewable energy products and solutions.

The Solaranda™, a shade structure that integrates solar photovoltaic panels into roof structures, provides both shade and electricity for homes and businesses. Already, the systems have been pre-engineered to meet countrywide building code requirements. The Solaranda™ kits include steel interior beams and posts with an aluminum covering that provides a lifetime warranty and No-Maintenance structure for the solar panels.

Michael Coskun, Vice President of GWS Technologies, stated, “The Solaranda is innovative, creative, and just the solution to give the solar industry a boost. The Solaranda appeals to a large consumer base and gives virtually everyone the opportunity to save money and lower their electric bills.”

Nichole Koontz, President of EnergyPro, Inc., added, “EnergyPro is very excited about partnering with GWS to distribute our Solaranda(TM) kits. It is a great option for installers nationwide to offer a new and unique product to their clients and that qualifies for all rebates and tax credits.”

Let us hear your thoughts below:

Even the Bond Market Requires Due Diligence

Most investors are aware that a balanced portfolio of stocks, bonds and other investments offer the best method of investment stability, and (likely) profitability over time. Some might say bonds offer the most safety along with treasuries of a like nature. In many instances, this may be true. But in others it may be less so. Where a currency is based on trust and a country’s ability to support that currency through borrowing (where the gold standard does not apply), bonds rely on the ability to pay rate of return. If the rate of return is not supported, the bond, financial backs of that bond and the bond issuer fall.

In recent days, Dubai has found itself in this plight. It has asked for additional time to pay out its interest on $3 billion in bond payments. Some may say $3 billion for an emirate such as Dubai is very little. In a certain way this may be correct, but the underlying trust in the bond, and the fact that overall debt incurred by the emirate is not published, is diminished. In relative terms, the overall issue in this particular case seems to come from over building and the likely idea that the emirate does not want to go to its other emirate partners for help (giving up control, as-it were) and that there may be further financial issues to come.

So the overall point, as illustrated, is that a balanced portfolio does require a blending of differing investment vehicles, but that even when investing in the safest classes one must be wise and see what the state of that vehicle sector is. It is not enough to just think “bonds or treasuries are the safe move.” Which bonds and which treasuries are the safe move for a portion of the portfolio? One must also consider what circumstance is the issuer in? After consulting a registered investment advisor, remember that even a country can get into trouble. Bonds and treasuries are generally a safe bet but doing one’s homework is paramount.

Let us hear your thoughts below:

Omnicity Corp. (OMCY.OB) Ensuring Effective Support for Growing Customer Base

November 25, 2009

Omnicity Corp., best known as the Midwest’s largest fixed Wireless Internet Service Provider, also provides a wide range of basic computer and networking services for both business and residential customers. These services have become increasingly important as the company rapidly expands its ISP base because customers generally prefer support from someone that can work directly with the ISP provider for network-related problems or setup issues. The fast growing company specializes in bringing broadband services to non-urban areas, previously underserved, and their basic repair and networking services augment this.

Omnicity’s in-house and on-site computer repair services are considered trusted and high-quality. Work is always guaranteed and comes at an affordable rate. Some of the most popular computer repair services offered by the company include:

• New computer setup
• Antivirus program installation
• Virus removal, repair, and protection
• Anti-spam software installation
• Data backup

Equally important are the network services the company provides. Technicians offer comprehensive network consulting and solutions, and are able to support both small and large organizations. More than just a problem solving service, they will work with a business from the earliest planning stages to help set and achieve critical goals tailored to meet specific needs. Coming from the ISP perspective, Omnicity views client relationships as long term, unlike most support service companies. This forward looking approach ends up saving companies both money and headaches.

Omnicity’s wireless broadband services give businesses in non-urban areas the affordable high-speed Internet access and advanced communications solutions that every business needs. They provide the communications infrastructure required to drive economic development, allowing non-urban areas to compete successfully with large cities. This is good for the communities and for the country, since it allows companies to locate in less expensive areas.

For residential users, Omnicity opens up a world of information and applications that they would not otherwise have, and gives them the basic technical support that residential users often need.

Let us hear your thoughts: Omnicity Corp. Message Board

Clenergen Corp.’s (CRGE.OB) Management Leads Innovative Push into Renewable Energy

Clenergen Corp. is approaching the renewable energy/biofuels sector from a unique perspective – an agronomy/ plantation standpoint rather than from a purely technical/engineering standpoint. Clenergen’s goal is produce high-density, short-rotation biomass (non-food) crops to use as feedstock for advanced gasification technologies to produce electricity.

The company is led by an outstanding management group. Here is a brief overview of the team:

Dr. Arvind Pandalai, Non-Executive Group Chairman

Dr. Pandalai has 32 years of experience in a number of areas including: international trading, export and import management, market research, joint ventures, strategic planning, project and financial management. He has also won a number of management awards in his native India.

Robert Kohn, Non-Executive Vice-Chairman

Mr. Kohn has been chairman/CEO, president/COO, and co-founder of three start-up public companies with a combined market cap of over $1.5 billion. He was also a president of a subsidiary of Exelon, ranked #1 utility in the US, and president and founder of (energy trading) at Exelon.

Mark LM Quinn, Chief Executive Officer

Mr. Quinn has extensive international business experience in the Middle East, Africa, Russia, India and the Philippines. He was co-founder and CEO of D1 Oils PLC, developing D1 into the global market leader in biodiesel. Mr. Quinn also successfully oversaw the listing on the company on the UK’s AIM (Alternative Investment Market) in October 2004.

Dale Shepard, Chief Financial Officer

Mr. Shepard worked from 1973 to 1991 for global blue-chip company, General Electric. While at GE, he held the positions of: Director of Finance – GEM Polymers Ltd. Vice-President – GE Plastics Japan, Managing Director – GEM Chemicals Inc. From there he joined Kawasaki LNP NC in the engineering plastics subsidiary of Kawasaki Steel Corp. Over the eight years he was at Kawasaki, Mr. Shepard was involved with acquisitions in the US, UK, France and Germany which resulted in the tripling of European sales over five years.

Jessica Hatfield, Executive Vice-President

Ms. Hatfield created The Media Vehicle in 1994, a company that provided advertising alternatives to traditional media. In 2004, she was invited to join Leaders Quest, an international organization that develops existing and future world leaders.

Let us hear your thoughts: Clenergen Corporation Message Board

Spending Growth Rises as Inflation Seems Manageable to Fed Despite Job Market

Several recent data points indicate consumer confidence is on the mend, promising signs of an economic recovery.

The Commerce Department reported today a 0.7% rise in consumer spending for last month, which is a good turnaround from the 0.6% decline in September.

With income also up 0.2%, marking the second month of rising income, and the best performance yet since the August jump of 1.3% when the Cash for Clunkers program kicked off, the spending environment is starting to loosen.

Because consumer spending accounts for nearly 70% of economic activity, this rebound in spending is a good indicator of the resilience of consumers. This sentiment was echoed by President of ClearView Economics, Ken Mayland who warned not to “count consumers out”, urging that they are making a significant “contribution to the recovery”.

Fed officials and other leading economists however remain skeptical regarding other fundamentals like unemployment and the tightness of credit markets. If consumers cannot borrow to finance homes and other major purchases, it could lead to a flagging recovery.

With Wednesday’s spending data painting a rosier picture though, the fear of a second major dip emerging in the recession waned marginally despite the nagging concern over how slow spending may be next year.

Consumer spending beat estimates by 0.2%, with income remaining unchanged, forcing savings (as a percentage of after-tax income) down to 4.4% in Oct., off from 4.6% in September.

Durable goods (cars, appliances, etc.) attracted the most spending of any category, and were up 2.1% last month after falling 8.5 percent in September.

Spending on “nondurables”, like food and clothing, was off somewhat, falling from 0.7% in Sept. to 0.4%, a potential indicator that people’s fears of a major downturn occurring have softened. While the Commerce Department report did not offer details for specific goods, it did contain information showing the service sector rebounded slightly as well, with consumers putting in an additional 0.2% to add to September gains.

Excluding food and energy, inflation rose 1.4% last year, falling comfortably within the Fed’s accepted range, prompting the Fed to maintain record-low interest rates, in order to nurture the recovery. Many economists foresee interest rates remaining low through the year and into part of 2010.

A 2.8% growth rate in the economy last quarter, after falling for four quarters in a row, was reported by the government Tuesday. While many economists expect growth to slow next year, claiming a floor of around 1%, Ken Mayland went on record as saying this year could close out as high as 3% depending on how loose people are over the holidays.

Let us hear your thoughts below:

Stock Guru Featured Company: Quasar Aerospace Industries, Inc. (QASP.PK)

Quasar Aerospace Industries, Inc. is the holding company for a group of aviation related entities that strengthens the company through their union. Quasar is focused on retaining the individual corporate cultures of their wholly owned subsidiaries while reaping the synergistic benefit of their combined union.

Quasar Aircraft Company (QAC) is a Nevada corporation owned by the current principals of QAI. QAI will be responsible for the manufacture of the Very Light Jet (VLJ) and a new advanced trainer aircraft. Quasar Aircraft Company is developing a four seat trainer aircraft and will be the developer of a twin engine, six seat very light jet aircraft.

Atlantic Aviation, Inc. operates a flight school at Herlong Airport in Jacksonville, Florida. The company, particularly in its franchise phase, offers a significant internal market for Quasar aircraft enabling QAC to achieve profitability sooner than would have been possible otherwise.

Quasar Development Corporation (QDC) is focused on developing the Quasar line of aircraft. A highly talented team with extensive managerial and engineering experience is in place to direct QDC’s operations.

Quasar Financial Corporation (QFC) provides significant assistance to the company’s sales force by enabling them to offer “One Stop Shopping” for the customers’ acquisition, financing, and insurance needs.

Aviation Import-Export, Inc. (AIE) has been established to meet the financial protocols of lenders, and to facilitate the transfer of funds among the various relevant entities in the enterprise.

Let us hear your thoughts: Quasar Aerospace Industries, Inc. Message Board

Stock Guru Featured Company: DecisionPoint Systems, Inc. (DNPI.OB)

DecisionPoint is focused on developing enterprise wireless and mobile computing solutions for customers’ needs. In short, they bring the field workers into office in real time. Crucial information and transactions are immediately transmitted, improving accuracy and efficiency for the client.

The enterprise mobile computing industry has standardized several key technologies over the past several years and DecisionPoint has been front and center in this evolutionary process in adapting mobile units to customer’s needs. The company has well established itself in this industry and when opportunity knocked in the Field Mobility niche Decision Point was prepared to answer the call.

DecisionPoint’s customers include: Liz Claiborne, PETCO Animal Supplies, Nike, Nordstrom and Grocery Outlet. Manufacturing companies include Dade Behring (Division of Siemens), Sargent Manufacturing (Division of ASSA Abloy), Timken Corp., Swiss Army Brands, Smith & Wesson and pharmaceutical companies such as Pfizer and Celgene.

Let us hear your thoughts: DecisionPoint Systems, Inc. Message Board


Select A Month



Select A Category
  • No categories
  • Newsletter Signup

    Stay ahead of the pack with QualityStocks and receive "The QualityStocks Daily", our summary formatted newsletter containing stock tips from hundreds of online investment newsletters.

    Rotate your device 90° to view site.